`
Saturday, 24 June 2017

Specials News

  • Anuradha Rajput: Enjoy challenges to overcome them

    Specials |  Influencers | By BioSpectrum Bureau | 0 Comment | 06 Mar, 2013

    I received my MSc in Biochemistry in 1986, and my PhD in Biochemistry in 1992 both from the University of Mysore in India. I started my career working my way up through various hospital pos...Read more

  • Life expectancy gains worldwide: WHO

    Specials |  Analysis | By BioSpectrum Bureau | 0 Comment | 21 May, 2014

    Singapore: People everywhere are living longer, according to World Health Statistics 2014 and women are living longer than men with Japan, Spain and Singapore having longest life expectancy...Read more

  • Sinopharm demonstrates king size growth, yet again

    Specials |  Analysis | By Amrita Tejasvi | 0 Comment | 31 May, 2013

    Sinopharm, a dominant name in the distribution of pharmaceutical and healthcare products in China, continues to grab a large chunk of market share and widened its geographical coverage of...Read more

  • Asia's Fastest 50 bio-firms shine

    Specials |  Opinion | By BioSpectrum Bureau | 0 Comment | 12 Jun, 2013

    The annual list of Asia's fastest growing pharma companies, compiled painstakingly by the BioSpectrum Asia team, is out. A remarkable aspect of the growth of companies in 2012 is the gravit...Read more

  • MenAfriVac wins BioSpectrum product award for fight against meningitis

    Specials |  Influencers | By Vipul Murarka | 0 Comment | 15 Mar, 2013

    Neisseria meningitidis (meningococcus) is a cause of the contagious bacterial meningitis that can lead to life-threatening infections in infants, children and young adults. Studies have ind...Read more

  • Q-Sera puts snake venom to blood collection use

    Specials |  Influencers | By Saptarshi Chaudhuri | 0 Comment | 15 Aug, 2012

    Q-Sera is a start-up firm that has put the lethal property of coagulation present in snake venom to good commercial use. The technology behind Q-Sera involves coating blood collection tubes...Read more

  • Dr. Reddy's makes a mark in the US generics market

    Specials |  Analysis | By Amrita Tejasvi | 0 Comment | 04 Jun, 2013

    Striking profit on a high note, Dr. Reddy's crossed $1.5 billion worth of business in 2012, marking a growth of 22 percent. Dr. Reddy's generic version of fondaparinux, used for prophylax...Read more

  • eHealth Access redefines healthcare in India

    Specials |  Influencers | By Vipul Murarka | 0 Comment | 16 Jan, 2013

    India-based start-up, eHealth Access (formely known as DialurDoctor) was established in the city of Hyderabad in 2010. Since its inception, the firm has revolutionized the healthcare space ...Read more

  • The breakthrough really is to explore new chemical classes for TB treatment'

    Specials |  News | By Saptarshi Chaudhuri | 0 Comment | 21 Mar, 2012

    Novartis Institute for Tropical Diseases (NITD) is a public-private partnership between Novartis and the Singapore Economic Development Board and involves more than 100 international scient...Read more

  • Aurobindo Pharma revamps strategy to accelerate growth

    Specials |  Analysis | By Amrita Tejasvi | 0 Comment | 04 Jun, 2013

    Aurobindo Pharma, ranked among the top pharmaceutical company in India, clocked $1 billion revenue in 2012. Aurobindo has developed its market base in over 125 countries across the globe ...Read more

  • Video message from women leaders in bioscience

    Specials |  Influencers | By Vipul Murarka | 0 Comment | 05 Mar, 2013

    We come across several women in the field of biosciences at the graduation and post-graduation level of education. However, there are only those select few who are able to climb the ladder ...Read more

  • Challenge No 6: Regulatory hurdles

    Specials |  Analysis | By Narayan Kulkarni | 0 Comment | 17 May, 2012

    The regulatory environment for life sciences companies is known for its challenging nature. The framework is confusing and at times overshoots the understandable need to protect patients wi...Read more

  • Nanoparticles: A unique approach to cancer treatment

    Specials |  News | By Nandita Singh | 0 Comment | 14 Mar, 2012

    Nanoparticles as a drug delivery system enables unique approaches for cancer treatment. Over the last two decades, a large number of nanoparticle delivery systems have been developed for ca...Read more

  • Challenge No 4: Fund crunch

    Specials |  Analysis | By Narayan Kulkarni | 0 Comment | 17 May, 2012

    Lack of appropriate funding for early- to mid-stage innovation companies, limited local capital, local grants for small biotechnology firms related to the percentage of GDP spent on researc...Read more

  • XCode decodes DNA, wins BioSpectrum award

    Specials |  Influencers | By Vipul Murarka | 0 Comment | 15 Mar, 2013

    Dr Saleem Mohammad, who founded XCode Life Sciences in December 2010, first had the idea of starting this company while he was pursuing his PhD in Bioinformatics from the University of Nebr...Read more

  • Dr Anu Singh: Pick biotech only if you are inspired by it

    Specials |  Influencers | By BioSpectrum Bureau | 0 Comment | 05 Mar, 2013

    As Albert Einstein put it, "The world as we have created is a process of our thinking. It cannot be changed without changing our thinking." I am a firm believer that science teaches us to b...Read more

  • Women in life sciences – A peep into the lives of inspirational figures

    Specials |  Influencers | By BioSpectrum Bureau | 0 Comment | 01 Mar, 2013

    We come across several women in the field of biotechnology at the graduation and post-graduation level of education. However, there are only those select few who are able to climb the ladde...Read more

  • Challenge No 9: Price cuts by govt

    Specials |  Analysis | By Narayan Kulkarni | 0 Comment | 17 May, 2012

    Continuous drug price cuts will further squeeze margins for both multinational and domestic pharma. "The National Reform and Development Commission (NRDC), China's pricing regulatory body, ...Read more

Survey Box

Will Asia- Pacific healthcare IT market hit the double digit growth in the next five years?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls